Skip to content

Author

D. Ezhilarasan

We have 4 of 148 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Metabolism-driven hepatotoxicity of 5-fluorouracil: molecular mechanisms and future therapeutic directions.

5-Fluorouracil (5-FU) is a widely used chemotherapeutic agent for the treatment of various solid malignancies; however, its clinical application is also associated with hepatotoxicity. As the liver is the primary site of 5-FU metabolism, excessive accumulation of the drug and its metabolites can lead to hepatic injury...

Sharmila Muthusethupathi, D. Ezhilarasan · 0 citations
Open access Jul 2026

Understanding regional differences in MASLD: the Indian perspective

This commentary highlights the growing burden of lean MASLD, the importance of visceral adiposity and cardiometabolic dysfunction, and population-specific genetic influences in Indian populations.

Karthik Shree Harini, D. Ezhilarasan · 0 citations
Aug 2026

Biosynthesized silver nanoparticles from Gelediella acerosa as a potent antibacterial agent against Multidrug-resistant wound isolates.

The biosynthesized AgNPs exhibited potent antibacterial activity against multidrug-resistant wound pathogens by disrupting bacterial membrane integrity, along with significant antioxidant and antidiabetic properties.

R. Snega, Aruchamy Mohanprasanth, Jeyasingh Immanuel Suresh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.